Drinex

Quick links to important sections

Drinex

Treatment option: Asthma, Bronchospasm

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Drinex

Property Description
Active Ingredients Ibuprofen and Codeine Phosphate
Form Oral Capsule (typically Immediate-Release)
Pharmacological Class Combination Analgesic (NSAID + Opioid)
General Purpose Short-term relief of moderate to severe acute pain
Origin Synthetic (Ibuprofen) and Semi-Synthetic (Codeine)

Drinex is a potent, prescription combination medication classified primarily as an analgesic and anti-inflammatory agent, typically formulated as an oral capsule. It belongs to the therapeutic class of strong pain relievers and is clinically recognized for its efficacy in managing severe pain.


Drinex: What Type of Medicine Is It?

This drug is a synthetic pharmaceutical product intended for systemic administration, meaning its active ingredients are absorbed into the bloodstream. The combination structure is utilized when single-ingredient pain medications are insufficient. The combination of an NSAID with an opioid is a key differentiating factor from over-the-counter pain relievers, allowing it to address pain through two separate mechanisms simultaneously.

What is Drinex Made Of? (Active Components)

Drinex contains two principal active ingredients: Ibuprofen and Codeine Phosphate. Ibuprofen is a fully synthetic anti-inflammatory agent, while Codeine is a naturally derived or semi-synthetic opioid alkaloid that acts centrally on the nervous system.

The formulation is designed to provide synergistic pain control. The Codeine component is a central nervous system depressant that changes how the body feels and responds to pain. Due to this specific composition, Drinex offers a higher level of pain intervention than many other oral options.

What Conditions Does Drinex Generally Help With?

Drinex is generally prescribed to provide powerful, short-term relief from moderate to severe acute pain that has not been adequately managed by non-narcotic options. A typical neutral use scenario would be for pain control following a minor surgical procedure or a dental extraction. Its use is specifically reserved for the short-duration management of acute symptoms, distinguishing it from medications aimed at managing chronic conditions.

Regulatory References

  1. EMA review on Ibuprofen
  2. Codeine: MedlinePlus Drug Information

What side effects are possible with Drinex?

Possible Side Effects and Safety Information

The safety profile for this combination medicine, which contains Ibuprofen (an NSAID) and Codeine Phosphate (an opioid), is structured based on official regulatory classifications.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized based on their documented frequency in clinical use, as reflected in official prescribing information:

  • Common Reactions: These include effects largely related to the gastrointestinal system and central nervous system. Officially listed common reactions include nausea, vomiting, constipation, dizziness, somnolence (drowsiness), and headache.
  • Rare/Very Rare Reactions: Less frequent but more serious risks are officially documented. These include severe haematological disorders, acute renal failure, hepatic abnormalities, and serious gastrointestinal events such as bleeding and perforation.

System-Organ Classes and Serious Adverse Reactions

Side effects are officially grouped by the body system affected. The most frequently involved are the Gastrointestinal Disorders (due to the Ibuprofen component) and Nervous System Disorders (due to the Codeine component).

Serious Adverse Reactions officially highlighted in labeling include gastrointestinal bleeding and perforation associated with NSAID exposure, and the risk of respiratory depression linked to the opioid component. Severe hypersensitivity reactions are also listed as a rare risk.

Population and Duration Safety Considerations

Safety constraints and risks are formally defined for specific patient groups:

  • Older Adults: This population is noted in official documents as having an increased risk of serious adverse reactions, particularly gastrointestinal haemorrhage and renal impairment.
  • Duration of Use: The risk of developing physical or psychological dependence on the Codeine component is associated with prolonged or repeated use, as the medicine is intended for short-term pain relief. Similarly, the risk of serious gastrointestinal events is tied to a longer duration of exposure.

The regulatory label restricts use in individuals with severe uncontrolled heart failure, severe renal failure, or active peptic ulceration.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of Drinex, due to its Ibuprofen and Codeine components, is recognized by regulatory authorities as a serious, potentially life-threatening event. Immediate medical attention must be sought if an overdose is suspected or confirmed.

Documented Manifestations

Overdose presentation involves a dual toxicological profile. Signs of severe Codeine toxicity include profound Central Nervous System (CNS) depression, somnolence, and respiratory depression which can progress to respiratory arrest. Manifestations of Ibuprofen toxicity include severe gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), CNS findings like nystagmus or tinnitus, and progression toward acute kidney failure or hepatic damage. Life-threatening outcomes, such as circulatory failure and coma, are officially documented.

Regulatory Action Required

Regulatory labeling mandates that emergency services must be contacted immediately. Hospital monitoring is required, as complications like severe hypotension or organ failure may develop. Specific management involves symptomatic and supportive treatment, including ensuring a patent airway. Naloxone is specified as a potential intervention to reverse the effects of opioid-induced respiratory depression, though no specific antidote is known for the Ibuprofen component. The risk of severe outcomes is noted to be greater in patients with existing renal or hepatic impairment.

Therapeutic Uses of Drinex

What Drinex Treats: Main Uses and Benefits

Drinex is considered relevant for the short-term management of acute pain that registers as moderate to severe in intensity and is commonly used when groups of symptoms create noticeable functional strain and require additional symptomatic support. As a combination painkiller that treats different types of aches and pains, this supportive relief is commonly used during phases when symptoms become more noticeable.

The medication is relevant in clinical settings marked by symptoms related to inflammatory or irritative states, including: intense musculoskeletal pain, severe backache, rheumatic episodes, and acute pain following dental extractions or minor surgical procedures. This combined approach helps address symptom clusters that may become intense or disruptive and contributes to improved comfort during difficult, temporary episodes of recovery.

“The therapeutic benefit offers symptomatic relief that may help patients cope more steadily with difficult episodes, contributing to easing the overall symptom load during symptomatic phases.”


Quick Fact: Support for Intense Acute Pain

Used when symptoms intensify and short-term symptomatic support is appropriate, providing comfort when additional support for symptom management is needed.

Eligibility and Restrictions for Use

Drinex, a combination medication containing an opioid analgesic (hydrocodone) and other pain relievers (acetaminophen and either ibuprofen or phenylephrine, depending on the specific formulation), is generally indicated for the short-term management of severe acute pain when non-opioid options are insufficient.

Patients Who May Be Prescribed Drinex

  • Individuals experiencing pain following surgery or severe dental procedures.
  • Patients with other acute medical conditions causing pain severe enough to require an opioid.

Contraindications (Who Should Not Use Drinex)

The medicine is not suitable for all patients. Due to the combination of active ingredients, several health conditions prohibit its use, including:

  • Significant respiratory depression or acute or severe bronchial asthma.
  • Known or suspected gastrointestinal obstruction, including paralytic ileus.
  • Severe liver impairment (hepatic disease), primarily due to the acetaminophen component's risk of hepatotoxicity.
  • Active gastrointestinal bleeding or a history of severe gastrointestinal issues (if the formulation contains ibuprofen).
  • Known hypersensitivity or allergy to hydrocodone, acetaminophen, ibuprofen, phenylephrine, or any other component of the specific Drinex formulation.
  • Children and adolescents (use is not generally recommended).

Healthcare providers must carefully assess a patient's medical history, especially a history of substance abuse, kidney or heart disease, and concurrent use of other medications containing acetaminophen or opioids, before prescribing Drinex.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Drinex is subject to numerous documented interactions with other medicinal products and substances, as specified in regulatory labeling. These interactions primarily involve changes to the drug's exposure in the body or additive pharmacological effects.

Interacting Product Category Type of Interaction and Regulatory Requirement
Strong CYP3A4 Inducers Co-administration is restricted as these agents significantly reduce Drinex plasma concentrations, potentially leading to a loss of expected effect. Specific examples include Rifampicin and the herbal product St. John's Wort.
Strong CYP3A4 and P-gp Inhibitors Co-administration results in a substantial increase in Drinex systemic exposure. Concomitant use with agents such as Ketoconazole or Ritonavir requires careful monitoring.
Other CNS Depressants Co-administration may result in additive effects on the central nervous system, including increased sedation. This includes products containing alcohol.
QT-prolonging Agents Combining Drinex with other medicinal products known to prolong the QT interval requires caution due to an increased risk of additive electrical effects on the heart.
Antacids / Metal Ions Physical interaction in the gut may reduce the absorption of Drinex. Administration must be temporally separated (e.g., at least 2 hours before or 4 hours after) these products.

The official interaction profile categorizes these co-administrations based on risk severity, ranging from combinations that are not permitted to those that require heightened clinical supervision or specific administration timing constraints. Warnings are provided against combining with strong inducers of drug metabolism due to the resulting significant reduction in drug exposure.

Mechanism of Action

How Drinex Works: Mechanism of Action

Dual Mechanism: Central Receptor Agonism and Peripheral Enzyme Inhibition

Drinex acts via two non-overlapping mechanistic domains: Ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce peripheral inflammatory mediators, while the active metabolite of Codeine activates mu-opioid receptors (MOR) to block central pain signal transmission. This dual action targets both the initiation and the processing of the nociceptive signal, resulting in modulation of the nociceptive system.


Modulating the Arachidonic Acid Pathway via Enzyme Inhibition

The Ibuprofen component specifically engages the arachidonic acid cascade by competitively inhibiting the COX enzymes. This action restricts the synthesis of **Prostaglandin E2 ( PGE2), a mediator associated with peripheral nociceptor sensitization. This enzyme inhibition alters the physiological threshold for nociceptor stimulation at the site of tissue injury.


Interrupting Central Signal Transmission via Opioid Receptors

The central mechanism relies on Codeine's conversion into Morphine, which acts as an agonist at the mu-opioid receptor in the spinal cord and brainstem. Activation of MOR results in the hyperpolarization of neurons and a decrease in neurotransmitter release, thereby suppressing the flow of the nociceptive signal to higher brain centers. This action alters the regulatory feedback within central pathways, resulting in a functional consequence to signal flow.

Dosage and Administration Information

How to Use Drinex: Official Administration Guidelines

Drinex (Ibuprofen and Codeine Phosphate) is administered strictly via the oral route as a tablet or capsule. The official usage protocol is defined by specific dose, frequency, and duration limits that must be adhered to.


Dosing Schedule and Frequency

Administration involves taking one or two tablets (or equivalent capsules) per dose. Dosing is taken on an as-needed basis for symptoms, with a required interval of at least four to six hours between doses. The maximum quantity permitted is six tablets (or equivalent capsules) within a 24-hour period. This maximum limit applies to short-term regimens.


Procedural and Duration Constraints

The medicine is designated for short-term use only, and the duration of treatment is strictly limited to a maximum of 3 consecutive days. The dose should be swallowed whole with fluid and may be taken with food or milk to assist with gastrointestinal tolerance.

Age-Related Restrictions: The use of codeine-containing products is generally contraindicated for children under 12 years due to specific risks related to metabolism. Dosage for older adults may require individual assessment or reduction due to potential functional impairment. In the event of a missed dose, the next dose should only be taken if the mandatory minimum time interval has passed; doses should not be doubled.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Drinex (Ibuprofen/Codeine)


Research Evidence for Acute Post-Operative Pain

Research into this combination medication has focused heavily on studies exploring acute, short-term pain following medical or dental procedures. Scientists have primarily relied on Randomized Controlled Trials (RCTs) and comprehensive meta-analyses that combine findings from multiple studies. This research examined outcomes related to physical discomfort, monitoring how patient-reported experiences were measured over defined time intervals after a single dose. The study populations were mostly adults presenting with moderate to severe pain following procedures like minor surgery or tooth extraction.

What remains uncertain is the applicability of these findings to long-term outcomes. The highest quality evidence is concentrated on the immediate, post-dose period, and there is limited information for long-term outcomes or durability of response. Furthermore, comparative evidence focusing on whether the Codeine component contributes to the analgesic effect over Ibuprofen alone is sometimes described as having mixed findings, highlighting a research gap.


Evidence in Other Acute Pain Contexts

The combination medicine was evaluated in studies involving other kinds of acute, disruptive episodes, such as pain related to extremity injuries (e.g., in emergency department settings) and certain severe musculoskeletal pain episodes. In these settings, research examined outcomes related to physical discomfort using patient-reported pain scales. The research conducted in acute care settings often involved very short observation periods.

Review of Study Duration and Follow-Up

The evidence landscape for this combination analgesic relates primarily to acute symptom patterns. The vast majority of the high-quality research involves immediate-term follow-up durations, focusing on observations following a single dose over periods such as 6 to 8 hours. The existing data primarily show patterns related to how symptoms evolved in the observed populations during the first few hours after use.


Evidence in Specific Patient Groups

Research has explored outcomes for certain subgroups within the adult population. However, comprehensive, dedicated studies focusing on specific patient groups are generally insufficient. The research highlights that patterns related to individual variability were observed in some studies. This variability means that data for certain groups remain insufficient to draw strong, universal conclusions.

Research Gaps and Uncertainty

Scientific and regulatory analyses have identified key areas where the research evidence remains limited or where certainty remains low. A primary focus of scientific discussion is the incremental contribution of the Codeine component. Furthermore, a significant research limitation is the role of individual variability in how the body processes the medication.

Key Studies & References

  1. Codeine for Acute Extremity Pain (Canadian Journal of Health Technologies)
  2. Oral Analgesics for Acute Dental Pain (ADA-endorsed guidelines/CDC)

Frequently Asked Questions (FAQ)

Common questions about Drinex (FAQ)


Q: Has Drinex been studied in children or adolescents?

Regulatory guidelines and product information primarily focus on the approved adult population. The medicine is generally contraindicated (should not be used) for children under 12 years of age due to risks related to the metabolism of the codeine component. Official documents typically do not contain detailed study results for patient groups where the medicine is not approved.


Q: Are there any known issues combining Drinex with herbal supplements?

Yes, official regulatory documents explicitly note a risk of interaction with certain herbal supplements. For instance, the label mentions the herbal product St. John's Wort because it can significantly reduce the amount of Drinex in the body, potentially leading to a loss of the expected pain-relieving effect.


Q: What happens if someone misses a dose of Drinex?

The official protocol regarding a missed dose advises that the patient should only take the next dose if the mandatory minimum time interval between doses has fully passed. The official protocol states that doses should not be doubled to make up for a missed one.


Q: What are the rules regarding combining Drinex with alcohol?

Official warnings advise caution and restriction regarding co-administration with substances that have additive effects on the central nervous system, which includes alcohol. Using Drinex with alcohol may result in increased sedation and associated serious risks due to its classification as a central nervous system depressant.


Q: Can Drinex cause stomach upset, and if so, how is that described in official sources?

Yes, stomach upset is a commonly reported effect. Official documents list nausea and vomiting as common reactions associated with use. The official administration guidelines mention that taking the medicine with food or milk may assist with gastrointestinal tolerance.


Q: Where can I find the official prescribing information for Drinex?

The comprehensive official information from regulatory agencies is typically found in documents such as the Summary of Product Characteristics (SmPC) in Europe or the Prescribing Information / Full Prescribing Information in the US. These documents are generally available on government drug agency websites like DailyMed.


Q: Can Drinex be crushed or split, according to the official documentation?

The official administration guidelines state the dose should be swallowed whole with fluid. This is the defined method of use described in the label.


Q: Can Drinex be used by someone who has a food allergy?

Official regulatory documents list all inactive ingredients (excipients) contained in the medicine. If a person has a specific food allergy, they should check the official label for ingredients such as lactose or specific dyes, which are sometimes noted as potential allergens in the product's composition.


Q: Is it common to feel a difference in energy levels when taking Drinex?

Official adverse reaction profiles list somnolence (drowsiness) and dizziness as common reactions to the medicine. These effects are related to the central nervous system activity of the drug and can certainly be perceived as a difference in usual alertness or energy levels.


Q: Is Drinex considered a scheduled drug or controlled substance?

Yes, due to the presence of the active opioid ingredient, Codeine, the medicine is legally classified as a controlled substance. Its exact classification (e.g., Schedule III or V) depends on the specific formulation and the regulations of the national jurisdiction.


Q: Is there any information on how Drinex affects driving or operating machinery?

Official warnings advise patients that they should not drive or operate machinery if they experience side effects that can affect mental status or motor skills. These effects include commonly reported side effects such as dizziness, light-headedness, or drowsiness/somnolence.


Q: How does Drinex compare to placebo in research studies?

Regulatory evidence reviews indicate that the medicine's efficacy (its ability to work) for acute pain has been established through clinical trials. These studies, such as Randomized Controlled Trials (RCTs), typically compare the drug's effect on pain relief directly against a placebo (an inactive substance).


Q: What should a person do if they suspect a rare side effect from Drinex?

Official guidance indicates that if a patient suspects a serious or rare side effect, they should discontinue use and seek appropriate medical care. Furthermore, regulatory bodies encourage patients and healthcare providers to report adverse reactions to the relevant national regulatory authority.


Q: Can people who are lactose intolerant or have gluten sensitivity use Drinex?

Official documents list all the medicine's inactive ingredients (excipients). Patients with sensitivities should review the official prescribing information to check for the presence of common fillers like lactose or wheat starch (which may contain gluten) within the specific product formulation.


Q: How is the long-term safety of Drinex evaluated in studies?

The medicine is officially intended only for short-term use, and the regulatory-reviewed research focuses heavily on this period. Official documentation confirms that there is limited information available regarding the long-term safety profile or the durability of the response for extended use.


Q: What are the signs of an allergic reaction to Drinex, according to official warnings?

Official warnings state that signs of a severe allergic or hypersensitivity reaction may include symptoms like hives, swelling of the face, or trouble breathing/wheezing. If these severe signs occur, use should be stopped, and immediate medical help should be sought.


Q: Does Drinex have any known interactions with specific foods or beverages?

Official documents explicitly list interactions with alcohol. Furthermore, the administration guidelines note that the dose may be taken with food or milk to help reduce the risk of gastrointestinal irritation. No other specific food-drug interactions are commonly highlighted in the patient-facing materials.


Q: What is the information on Drinex's use in people with kidney issues?

Official documents note that the medicine is generally contraindicated in cases of severe renal failure. Risk of serious adverse reactions, including renal impairment, is also noted for older adults.


Q: Is it true that Drinex is sometimes used in combination with other medicines?

The drug's official label extensively lists known interactions with many other medicinal products. These interaction warnings indicate that co-administration with other medicines can occur, and this often requires specific restrictions, adjustments, or careful monitoring.


Q: Are there any demographic factors (like gender or ethnicity) that affect how Drinex works?

Research evidence reviews highlight the existence of individual variability in how the body processes the medicine, which may be influenced by patient factors. Official analyses note that data for certain demographic groups remains insufficient to draw universal conclusions.


Q: How is the efficacy of Drinex measured in research?

In regulatory-reviewed research, the efficacy of the medicine is formally measured using patient-reported outcomes related to physical discomfort. This is primarily done through the use of validated patient-reported pain scales over specific time intervals.


Q: Why is Drinex taken at a specific time of day?

The official dosing schedule indicates that the medicine is administered on an as-needed basis for symptoms of acute pain. It is not linked to a fixed time of day, like morning or evening.


Q: Are there any reported instances of Drinex losing its effect over time?

Regulatory documents discuss the development of tolerance to the opioid component. Tolerance is a pharmacological term that means that the pain-relieving effect of the medicine may decrease over time, which may necessitate a review of the usage regimen.


Q: What does the term 'Drinex discontinuation' refer to in medical documents?

Discontinuation refers to the action of stopping the medicine. Official warnings note that stopping abruptly after regular use may lead to withdrawal symptoms because the body can develop physical dependence on the opioid component.


Q: Are there any specific warnings for people with heart conditions using Drinex?

The medicine is generally restricted for individuals who have severe uncontrolled heart failure. Additionally, regulatory warnings advise caution when combining Drinex with other medicinal products known to prolong the QT interval, which is a measure of the heart's electrical cycle.


Q: What is the chemical class or category Drinex belongs to?

Drinex is classified as a combination analgesic, which places it in the therapeutic class of strong pain relievers. This category is defined by its two active components: a Nonsteroidal Anti-Inflammatory Drug (NSAID) and an opioid.


Q: Does Drinex cause drowsiness or affect sleep patterns?

Somnolence (drowsiness) is officially listed as a common reaction associated with the medicine. This is expected due to the opioid component, which is a known central nervous system depressant.


Q: Is it normal to have mild headaches when first starting Drinex?

According to the official adverse reaction profile, headache is listed as a common reaction associated with the use of the medicine. Common reactions are those that are documented to occur frequently in the population using the drug.


Q: Are there any specific environmental conditions (like heat) that affect Drinex?

Official storage instructions mandate that the medicine must be protected from light, excess heat, and moisture to help ensure its stability and effectiveness up to the expiration date. It is recommended to keep the container tightly closed.


Q: What information is given about Drinex and breastfeeding?

Official documents state that the medicine's use is not recommended while breastfeeding due to the risk of serious side effects in the infant. This warning is based on the fact that the opioid component may pass into breast milk.


Q: Is Drinex a hormone or does it affect hormones?

Drinex is classified as a combination analgesic and is not a hormone. The ibuprofen component works by acting on COX enzymes to reduce inflammation, and the codeine component works by binding to opioid receptors in the nervous system to alter pain signals.

How should Drinex be stored and disposed of?

Official Storage and Disposal Requirements

Drinex, a combination product containing an opioid, requires strict adherence to labeled storage and disposal protocols as defined by regulatory authorities.

Requirement Category Official Regulatory Statements
Labeled storage temperature Store at controlled room temperature, typically 20C to 25C (68F to 77F).
Handling and protection The medicine must be protected from light, excess heat, and moisture, and must not be frozen. The container must be kept tightly closed.
Child-protection storage Keep out of the sight and reach of children and store securely in a safe place due to the opioid component.
Disposal instructions Dispose of unused or expired product immediately using a drug take-back program or mail-back envelope. If those options are not readily available, follow the specific instructions for disposing of controlled substances in the household trash or flushing, as per FDA guidance.

These instructions ensure product stability up to the expiration date and mandate special security measures to prevent unauthorized use of the controlled substance component.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Drinex found in:

A-Z Index: